HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopes.

AbstractBACKGROUND:
During early HIV-1 infection, immunodominant T cell responses to highly variable epitopes lead to the establishment of immune escape virus variants. Here we assessed a type 1-polarized monocyte-derived dendritic cell (MDC1)-based approach to selectively elicit cytotoxic T lymphocyte (CTL) responses against highly conserved and topologically important HIV-1 epitopes in HIV-1-infected individuals from the Thailand RV254/SEARCH 010 cohort who initiated antiretroviral therapy (ART) during early infection (Fiebig stages I-IV).
METHODS:
Autologous MDC1 were used as antigen presenting cells to induce in vitro CTL responses against HIV-1 Gag, Pol, Env, and Nef as determined by flow cytometry and ELISpot assay. Ultra-conserved or topologically important antigens were respectively identified using the Epigraph tool and a structure-based network analysis approach and compared to overlapping peptides spanning the Gag proteome.
FINDINGS:
MDC1 presenting either the overlapping Gag, Epigraph, or Network 14-21mer peptide pools consistently activated and expanded HIV-1-specific T cells to epitopes identified at the 9-13mer peptide level. Interestingly, some CTL responses occurred outside known or expected HLA associations, providing evidence of new HLA-associated CTL epitopes. Comparative analyses demonstrated more sequence conservation among Epigraph antigens but a higher magnitude of CTL responses to Network and Gag peptide groups. Importantly, CTL responses against topologically constrained Gag epitopes contained in both the Network and Gag peptide pools were selectively enhanced in the Network pool-initiated cultures.
INTERPRETATION:
Our study supports the use of MDC1 as a therapeutic strategy to induce and focus CTL responses toward putative fitness-constrained regions of HIV-1 to prevent immune escape and control HIV-1 infection.
FUNDING:
A full list of the funding sources is detailed in the Acknowledgment section of the manuscript.
AuthorsTatiana M Garcia-Bates, Mariana L Palma, Renee R Anderko, Denise C Hsu, Jintanat Ananworanich, Bette T Korber, Gaurav D Gaiha, Nittaya Phanuphak, Rasmi Thomas, Sodsai Tovanabutra, Bruce D Walker, John W Mellors, Paolo A Piazza, Eugene Kroon, Sharon A Riddler, Nelson L Michael, Charles R Rinaldo, Robbie B Mailliard, I4C and RV254 Study Groups
JournalEBioMedicine (EBioMedicine) Vol. 63 Pg. 103175 (Jan 2021) ISSN: 2352-3964 [Electronic] Netherlands
PMID33450518 (Publication Type: Journal Article)
CopyrightCopyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Epitopes, T-Lymphocyte
  • HLA Antigens
  • Peptides
Topics
  • Adult
  • Alleles
  • Amino Acid Sequence
  • CD4 Lymphocyte Count
  • CD4-CD8 Ratio
  • Conserved Sequence
  • Dendritic Cells (immunology, metabolism)
  • Epitopes, T-Lymphocyte (chemistry, immunology)
  • Genotype
  • HIV Infections (genetics, immunology, virology)
  • HIV-1 (genetics, immunology)
  • HLA Antigens (genetics, immunology)
  • Host-Pathogen Interactions (genetics, immunology)
  • Humans
  • Immunophenotyping
  • Middle Aged
  • Peptides (chemistry, immunology)
  • T-Lymphocytes, Cytotoxic (immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: